about
The molecular basis for load-induced skeletal muscle hypertrophyPsychedelicsSelective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice.Structural Determinants for the Binding of Morphinan Agonists to the μ-Opioid ReceptorFunctional Divergence in the Role of N-Linked Glycosylation in Smoothened SignalingOpioid receptors: Structural and mechanistic insights into pharmacology and signaling.Bone and skeletal muscle: Key players in mechanotransduction and potential overlapping mechanisms.Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor SignalingInvestigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritusA G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways.Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice.CXCR4: a virus's best friend?The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism.The impact of RGS and other G-protein regulatory proteins on Gαi-mediated signaling in immunity.Allosteric communication pipelines in G-protein-coupled receptors.Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling.Sequence-Specific Regulation of Endocytic Lifetimes Modulates Arrestin-Mediated Signaling at the µ Opioid Receptor.Computational insights into the subtype selectivity and "message-address-efficacy" mechanisms of opioid receptors through JDTic binding and unbinding.Identifying Functional Hotspot Residues for Biased Ligand Design in G-protein-coupled Receptors.Critical Role for Gi/o-Protein Activity in the Dorsal Striatum in the Reduction of Voluntary Alcohol Intake in C57Bl/6 Mice.Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity
P2860
Q26829477-7C2E08A8-2230-4D16-9309-46542594F874Q30359998-8BCBCE19-EEDC-4DA8-8AED-1E945218E5F6Q33911524-A30A9F2D-FC09-42E8-B1C0-FE3AE61997AEQ35747694-0ACFD930-A2A4-4A4F-8F09-49FCD3BBC3E0Q35751142-13F25643-BC37-4690-93A7-6BE22142B70BQ36096058-9E1F239C-213B-43A8-8371-DB7F2E587484Q36145137-55B9DFCC-1329-46E5-8597-34056B95D256Q36283874-3BABBA1D-3365-437F-9B4F-21F8C1ADAF19Q36539104-0B9E0FE7-72BF-49DF-804C-920748DA61AAQ36778728-853ACD4D-7049-497E-8EF8-D6CF7B62976CQ37642476-2F3111E8-98D3-40D6-A8A2-717E8B95E62EQ38209118-93359ABE-8993-482D-BD02-CD3106B6B8FEQ38444486-FEF0BB34-113C-4BCF-8947-7F196130FE4EQ38806373-98CDB8FD-9FB8-4EA3-B061-434D0E31740EQ38920318-66645F36-ABE5-46B3-ABA4-1A07DA510E93Q39021630-4B9BD8FF-3EB1-4E37-8DD3-0ADEE8B102CAQ40560867-3A6977DB-1251-4BF8-94CF-0B755A2F0F56Q44343075-018E5665-7262-4DEB-804D-C760478E9B87Q44349926-70A51E53-2ABE-4562-9C08-8BCDC1E3D91BQ49789726-0F4AE3AC-6979-4506-BF41-B0AC2AED36B4Q53281321-60EA244E-B4E6-4DC8-B960-62EBA06D2F1DQ58798205-59E10903-0997-4FB4-8F31-103B842B6DA1
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Functional selectivity of GPCR signaling in animals.
@en
type
label
Functional selectivity of GPCR signaling in animals.
@en
prefLabel
Functional selectivity of GPCR signaling in animals.
@en
P2860
P1476
Functional selectivity of GPCR signaling in animals.
@en
P2093
Laura M Bohn
P2860
P304
P356
10.1016/J.CEB.2013.11.010
P577
2013-12-22T00:00:00Z